|
1 Company |
|
0 Products |
|
0 Products |
|
2 Mechanisms of Action |
|
0 Trials |
|
5 News |
|
- | Trial termination: Hantavirus Transmission in Households in Chile (clinicaltrials.gov) - Jan 11, 2024
P=N/A, N=197, Terminated, Sponsor: University of New Mexico
Completed --> Terminated; This is not a clinical trial and was inadvertently added to the system.
- |||||||||| New P3 trial: Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS (clinicaltrials.gov) - Feb 10, 2015
P3, N=226, Completed, Sponsor: Green Cross Corporation
- Trial completion, Trial primary completion date: Hantavirus Transmission in Households in Chile (clinicaltrials.gov) - Dec 9, 2014
P=N/A, N=197, Completed, Sponsor: University of New Mexico
Completed --> Terminated; This is not a clinical trial and was inadvertently added to the system. Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Feb 2014
- | NN1213 / Novo Nordisk
Trial completion: A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=130, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Feb 2014 No longer recruiting --> Completed
- Trial completion: HTNV/PUUV: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines (clinicaltrials.gov) - Jan 29, 2013
P1, N=31, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
No longer recruiting --> Completed Active, not recruiting --> Completed
- | methylprednisolone sodium succinate / Generic mfg.
Trial completion: Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome (clinicaltrials.gov) - Jul 8, 2012
P2, N=66, Completed, Sponsor: University of New Mexico
Active, not recruiting --> Completed Recruiting --> Completed
- New P1 trial: HTNV/PUUV: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines (clinicaltrials.gov) - Dec 28, 2011
P1, N=31, Completed, Sponsor: U.S. Army Medical Research and Materiel Command